Personalized treatment in the eradication therapy for Helicobacter pylori

International Journal of Molecular Medicine

Volumn 27, Issue 2, 2011, Pages 255-261

  Jinda, Sayaka ^a   Nakatani, Kaname ^a,b   Nishioka, Junji ^b   Yasuda, Kazunari ^a,b   Soya, Yoshihiro ^c   Hayashi, Amiko ^a   Wada, Hideo ^a   Nobori, Tsutomu ^a,b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

^c TOYOBO CO LTD   (Japan)

Author keywords

Clarithromycin resistance; Helicobacter pylori; Self selective multi amplification primers polymerase chain reaction method; Single nucleotide primer extension method

Indexed keywords

BACTERIAL DNA; CLARITHROMYCIN; CYTOCHROME P450 2C19;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL ARTICLE; DNA EXTRACTION; DRUG EFFICACY; ENDOSCOPY; ERADICATION THERAPY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; PEPTIC ULCER; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH BIOPSY; STOMACH MUCOSA;

ANTI-BACTERIAL AGENTS; ARYL HYDROCARBON HYDROXYLASES; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; GASTRIC MUCOSA; GENETIC TESTING; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDIVIDUALIZED MEDICINE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME;

EID: 78751663199     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2010.569     Document Type: Article

References (24)

1. Warren JR and Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1: 1273-1275, 1983.
2. Asaka M, Satoh K, Sugano K, et al: Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 6: 177-186, 2001.
3. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K and Sugano K: Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15: 1-20, 2010.
4. Hiratsuka M: Development of simplified and rapid detection assay for genetic polymorphisms influencing drug response and its clinical applications. Yakugaku Zasshi 122: 451-463, 2002.
5. Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H, Ohashi K, Ishizaki T and Kaneko E: Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther 69: 158-168, 2001.
6. Bytzer P and O'Morain C: Treatment of Helicobacter pylori. Helicobacter 10: 40-46, 2005.
7. Furuta T, Shirai N, Kodaira M, Sugimoto M, Nogaki A, Kuriyama S, Iwaizumi M,Yamade M, Terakawa I, Ohashi K, Ishizaki T and Hishida A: Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori. Clin Pharmacol Ther 81: 521-528, 2007. (Pubitemid 46452299)
8. Stone GG, Shortridge D, Versalovic J, Beyer J, Flamm RK, Graham DY, Ghoneim AT and Tanaka SK: A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 41: 712-714, 1997. (Pubitemid 27098432)
9. Taylor DE, Ge Z, Purych D, Lo T and Hiratsuka K: Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 41: 2621-2628, 1997.
10. Debets-Ossenkopp YJ, Brinkman AB, Kuipers EJ, Van den Broucke-Grauls CM and Kusters JG: Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 42: 2749-2751, 1998.
11. Oleastro M, Ménard A, Santos A, Lamouliatte H, Monteiro L, Barthélémy P and Mégraud F: Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol 41: 397-402, 2003.
12. Perez Aldana L, Kato M, Nakagawa S, Kawarasaki M, Nagasako T, Mizushima T, Oda H, Kodaira J, Shimizu Y, Komatsu Y, Zheng R, Takeda H, Sugiyama T and Asaka M: The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7: 306-309, 2002.
13. Rimbara E, Noguchi N, Kijima H, Yamaguchi T, Kawai T and Sasatsu M: Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. Int J Antimicrob Agents 30: 250-254, 2007.
14. Chen S, Li Y, Yu C: Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance. J Gastroenterol Hepatol 23: 126-131, 2008.
15. Nikolausz M, Chatzinotas A, Táncsics A, Imfeld G and Kästner M: The single-nucleotide primer extension (SNuPE) method for the multiplex detection of various DNA sequences: from detection of point mutations to microbial ecology. Biochem Soc Trans 37: 454-459, 2009.
16. http://www.imm.ki.se/CYPalleles/default.htm
17. Fukushima-Uesaka H, Saito Y, Maekawa K, Ozawa S, Hasegawa R, Kajio H, Kuzuya N, Yasuda K, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Tohkin M and Sawada J: Genetic variations and haplotypes of CYP2C19 in a Japanese population. Drug Metab Pharmacokinet 4: 300-307, 2005.
18. Furuta T, Ohashi K, Kamata T, Takashima M, Kosuge K, Kawasaki T, Hanai H, Kubota T, Ishizaki T and Kaneko E: Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med 129: 1027-1030, 1998.
19. Kang JM, Kim N, Lee DH, Park YS, Kim JS, Chang IJ, Song IS and Jung HC: Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage. J Gastroenterol Hepatol 23: 1287-1291, 2008.
20. Zhao F and Wang J: Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis. Helicobacter 13: 532-541, 2008.
21. Vallone P, Just R, Coble M, Butler J and Parsons T: A multiplex allele-specific primer extension assay for forensically informative SNPs distributed throughout the mitochondrial genome. Int J Legal Med 118: 147-157, 2004.
22. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing 26: 142, 2006.
23. Ohara S, Kato M, Asaka M and Toyota T: Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol 33: 6-13, 1998.
24. Nakamura A, Furuta T, Shirai N, Sugimoto M, Kajimura M, Soya Y and Hishida A: Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction method. J Gastroenterol Hepatol 22: 1057-1063, 2007.